In a new trading update, SourceBio International has revealed plans to delist from the AIM market of the London Stock Exchange. The Nottingham-based provider of laboratory services says its board has conducted a review of the benefits and drawbacks to the company retaining its listing on AIM and maintaining its existing corporate structure. Subject to shareholder approval, [...]
